Literature DB >> 444913

Hypopituitarism in normal-pressure hydrocephalus.

S G Barber, N Garvan.   

Abstract

Hypothalamic hypopituitarism has been associated with the intermittent intracranial hypertension of "normal-pressure" hydrocephalus. Six patients with this condition were studied endocrinologically; five showed evidence of hypothalamohypophyseal insufficiency, and, though only one needed treatment, all needed continued assessment of their endocrine state during follow-up. Thus, hypothalamohypophyseal dysfunction is more common than might be expected. Tests of anterior pituitary function should be preformed before surgical intervention, as such dysfunction may adversely affect survival and the response to ventricular shunting.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 444913      PMCID: PMC1599470          DOI: 10.1136/bmj.1.6170.1039

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  3 in total

1.  Necrosis of anterior pituitary in humans. I.

Authors:  K Kovács
Journal:  Neuroendocrinology       Date:  1969       Impact factor: 4.914

2.  Hypothalamic hypopituitarism from "normal pressure" hydrocephalus.

Authors:  S G Barber; N Garvan
Journal:  Br Med J       Date:  1978-04-01

3.  Oestrogen amplification of LH-RH response in the polycystic ovary syndrome and response to clomiphene.

Authors:  F R Kandeel; W R Butt; D R London; S S Lynch; R L Edwards; B T Rudd
Journal:  Clin Endocrinol (Oxf)       Date:  1978-11       Impact factor: 3.478

  3 in total
  2 in total

1.  Hypothalamic-pituitary dysfunction in respiratory hypoxia.

Authors:  P D Semple; G H Beastall; W S Watson; R Hume
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

2.  Thyroid Hormones and Health-Related Quality of Life in Normal Pressure Hydrocephalus Patients before and after the Ventriculoperitoneal Shunt Surgery: A Longitudinal Study.

Authors:  Mindaugas Urbonas; Nijole Raskauskiene; Vytenis Pranas Deltuva; Adomas Bunevicius
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.